
Portfolio news
August 11, 2026

Ennov (the “Company”), a global provider of a unified compliance platform that streamlines regulatory, clinical, quality, and pharmacovigilance operations for life sciences and healthcare companies, today announced the appointment of Dr. Oxana Pickeral as Chief Executive Officer. Founder and outgoing CEO, Olivier Pâris, will join Ennov’s Board of Directors and continue to support the company as a Strategic Advisor.
Dr. Pickeral has spent her career at the forefront of innovation in life sciences technology, from her early work on the Human Genome Project to growing Amazon Web Services’ Healthcare & Life Sciences partner business, enabling modern cloud solutions across the industry. She joins Ennov most recently from Honeywell, where she served as Global Software and Connected Life Sciences business leader, and previously as President and CEO of Sparta Systems, a Honeywell company. Across her leadership roles, she has successfully scaled global companies at the intersection of life sciences, healthcare, and technology innovation to drive outstanding products and outcomes for all stakeholders in the ecosystem.
Dr. Oxana Pickeral
Chief Executive Officer - Ennov
Since founding Ennov in 1999, Olivier Pâris has led its development into a global business serving ~650 customers and over 500,000 users worldwide.
Olivier Pâris
Founder and outgoing CEO - Ennov
Under Pickeral’s leadership, Ennov will accelerate its ongoing efforts to embed AI across its unified platform, which is uniquely architected to enable agentic regulatory, quality, and clinical workflows tapping into its single data lake and highly configurable architecture. Further, the Company plans to establish a North American delivery and commercial hub to complement its existing footprint, while continuing to expand its international go-to-market capabilities in Europe and Asia. These priorities build on the recent investment in Ennov by Bregal Sagemount, a leading NYC-based growth-focused private equity firm, with participation from Ardian, a global private investment firm headquartered in France. Both firms bring extensive experience and resources in scaling global healthcare and life sciences technology companies with a focus on accelerating growth and innovation.
Gene Yoon
Managing Partner - Bregal Sagemount
Alexis Saada
Head of Growth - Ardian
About Ennov:
Ennov provides a comprehensive software platform to manage the most demanding processes of life sciences organizations in a compliant and efficient way. With over 25 years of experience, Ennov’s cloud-based solutions cover Regulatory Affairs, Pharmacovigilance, Quality, Clinical, and Commercial. Dedicated to innovation and excellence, Ennov’s solutions are used by ~650 customers and over 500,000 users worldwide, helping them to bring their products to market faster while maintaining compliance with regulatory requirements. For more information, visit en.ennov.com or follow us on LinkedIn.
About Bregal Sagemount:
Bregal Sagemount is a leading growth-focused private capital firm with $11 billion of cumulative capital raised. The firm provides flexible capital and strategic assistance to market-leading companies in high-growth sectors across a wide variety of transaction situations. Bregal Sagemount has invested in over 90 companies in a variety of sectors, including software, data & information services, financial technology & services, digital infrastructure, healthcare IT, and business & consumer services. The firm has offices in New York and Palo Alto. For more information, visit www.sagemount.com or follow us on LinkedIn.
About Ardian:
In a world of constant evolution, Ardian stands out for its ability to anticipate, adapt, and turn challenges into opportunities. As a global, diversified private markets firm with 22 offices and more than 350 investment professionals worldwide, we provide investment and customized solutions that reflect new economic dynamics and help our clients remain resilient in a changing world. We deliver multi-local expertise and long-term performance for our investors and partners as well as shared value for the broader society. Since Ardian’s inception in 1996, our pioneering approach to diversification and our ability to offer tailor-made solutions at scale have remained the heart of our strategy. Through commitment, knowledge and technology, we bring lasting value to our companies and contribute positively to the whole industry. Ardian currently manages or advises $200bn for more than 1,920 clients worldwide across Private Equity, Real Assets, and Credit. Ardian. Mastering change for lasting value. For more information, visit ardian.com.
Contact:
Ennov
Laure Bros
Chief Sales and Marketing Officer
lbros@ennov.com
Bregal Sagemount
Siqi Wu
Marketing & Communications Manager
Siqi.wu@bregal.com
Ardian
HEADLAND
ardian@headlandconsultancy.com